{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1613,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":1613,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"7e0583b6101f","filters":{"topic":"Acute Lymphoblastic Leukemia research"}},"results":[{"id":"W2060605982","doi":"10.1038/nature10725","title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","year":2012,"lang":"fr","type":"article","venue":"Nature","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1630,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"National Human Genome Research Institute; Children’s Oncology Group; National Institute of General Medical Sciences; Alvin J. Siteman Cancer Center; Alex's Lemonade Stand Foundation for Childhood Cancer; American Lebanese Syrian Associated Charities; National Cancer Institute; National Institutes of Health; Washington University in St. Louis","keywords":"Myeloid; Cancer research; Haematopoiesis; Neuroblastoma RAS viral oncogene homolog; KRAS; Biology; Epigenetics; RUNX1; ETV6; Stem cell; Immunology; Mutation; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.008763733482893441,"gpt":0.2764893003813343,"spread":0.2677255668984409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0008690588,0.0005176152,0.0006451078,0.0001806376,0.000277155,0.00006660273,0.0008852882,0.003371953,0.0006157709],"category_scores_gemma":[0.001043265,0.0003636585,0.0003540855,0.0009182437,0.0008677735,0.0002478484,0.0003608378,0.004031773,0.001562069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00182257,"about_ca_system_score_gemma":0.002106433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001375618,"about_ca_topic_score_gemma":0.00001240478,"domain_scores_codex":[0.9948152,0.0003598348,0.0006910787,0.0004865188,0.001595252,0.002052057],"domain_scores_gemma":[0.9950509,0.002091574,0.0003112297,0.001192975,0.0005143892,0.0008389026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00468731,0.002564775,0.09365118,0.003810492,0.004015711,0.0006953626,0.006554883,0.00008968214,0.04568595,0.008277725,0.660386,0.169581],"study_design_scores_gemma":[0.01835409,0.003499831,0.2834522,0.002780439,0.006804416,0.001825784,0.001008301,0.005994053,0.14141,0.0006369854,0.5325271,0.001706755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6565087,0.3106321,0.0004465147,0.004549426,0.008980332,0.00129857,0.0002630139,0.00007217501,0.01724916],"genre_scores_gemma":[0.9272718,0.005338397,0.001746856,0.0006656345,0.003392408,0.00005308184,0.00001941705,0.0001315178,0.06138093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3052937,"threshold_uncertainty_score":0.9998816,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2148202982","doi":"10.1056/nejmoa1403088","title":"Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1376,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institute of General Medical Sciences; U.S. Public Health Service; St. Jude Children's Research Hospital","keywords":"Lymphoblastic Leukemia; Tyrosine kinase; Cancer research; Philadelphia chromosome; Gene; Leukemia; ABL; Kinase; Medicine; Tyrosine-kinase inhibitor; Biology; Internal medicine; Chromosomal translocation; Genetics; Signal transduction; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01841410003234999,"gpt":0.2873532493310471,"spread":0.2689391492986971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001973319,0.0002865603,0.0009968559,0.0006824423,0.00008784622,0.00001717396,0.0002925545,0.0001561998,0.0004966318],"category_scores_gemma":[0.002747466,0.0001895061,0.000115454,0.0006564884,0.0001915084,0.000205612,0.00007574348,0.0008675756,0.00002973593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001294157,"about_ca_system_score_gemma":0.002018406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005191937,"about_ca_topic_score_gemma":0.00004660564,"domain_scores_codex":[0.9967007,0.000209391,0.001022047,0.0002670398,0.001194106,0.0006067408],"domain_scores_gemma":[0.9967952,0.001293366,0.0004304663,0.0003405889,0.0003406433,0.0007997115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.007832906,0.000402778,0.02076583,0.0004030569,0.0008005021,0.005479265,0.003660687,0.00140566,0.2016786,0.0007152975,0.1004394,0.656416],"study_design_scores_gemma":[0.4731745,0.01264741,0.04964681,0.008305651,0.001254169,0.02216482,0.001167767,0.03816472,0.01275584,0.002742142,0.377059,0.0009172242],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9586998,0.001062454,0.02077538,0.009552251,0.001167054,0.0003183236,0.000002720328,0.00004063817,0.00838134],"genre_scores_gemma":[0.9883128,0.0003597705,0.003490575,0.001250813,0.00454459,0.000003118821,0.00001023668,0.00005164517,0.001976446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6554987,"threshold_uncertainty_score":0.7727836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2145648574","doi":"10.1016/s0016-5085(00)70140-5","title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","year":2000,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1002,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Thiopurine methyltransferase; Pharmacogenomics; Metabolite; Medicine; Therapeutic drug monitoring; Pharmacology; Inflammatory bowel disease; Mercaptopurine; Pharmacogenetics; Leukopenia; Internal medicine; Drug; Gastroenterology; Toxicity; Therapeutic index; Azathioprine; Genotype; Disease; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.02214885717945556,"gpt":0.279254232939504,"spread":0.2571053757600484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003944692,0.0001649407,0.0002690752,0.0001439856,0.00003492241,0.00001105129,0.00009657365,0.00004784085,0.0002300842],"category_scores_gemma":[0.00003882241,0.0001442239,0.00007077579,0.00004203746,0.0001318885,0.00005264755,0.00003375198,0.0001426737,0.00001633314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002412171,"about_ca_system_score_gemma":0.0001584085,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001499149,"about_ca_topic_score_gemma":0.00001157794,"domain_scores_codex":[0.9985644,0.00008096336,0.0002868084,0.0003222367,0.0002293294,0.0005162838],"domain_scores_gemma":[0.9993349,0.00002930028,0.00003530261,0.0002155252,0.00008238882,0.0003025481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05060958,0.0006728749,0.8613002,0.0002272849,0.0004189876,0.0003010274,0.0003510283,0.0001418998,0.03165463,0.00007751574,0.001774244,0.05247075],"study_design_scores_gemma":[0.03454322,0.001409592,0.9267498,0.00004020945,0.0001202664,0.0001571144,0.00002613786,0.005140408,0.0009072332,0.000174926,0.03058445,0.0001466361],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955799,0.0009109338,0.000235621,0.002219147,0.00006050673,0.000862643,0.00002964681,0.00002712462,0.00007445357],"genre_scores_gemma":[0.994693,0.001506003,0.000579338,0.002587705,0.0001716673,0.0002313192,0.00002576985,0.00003119472,0.0001739488],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06544964,"threshold_uncertainty_score":0.5881279,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168571815","doi":"10.1093/jnci/93.8.618","title":"Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer: Childhood Cancer Survivor Study","year":2001,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":740,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; Children's Cancer Research Fund; U.S. Department of Health and Human Services","keywords":"Medicine; Cancer; Internal medicine; Cohort; Oncology; Poisson regression; Confidence interval; Incidence (geometry); Retrospective cohort study; Breast cancer; Cohort study; Population","retraction":null,"screen_n_in":null,"score":{"opus":0.02794327525745455,"gpt":0.331331682995897,"spread":0.3033884077384424,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001150949,0.0002881973,0.0007408695,0.0005202274,0.0001399494,0.00002956148,0.0006903873,0.0001413197,0.0009421053],"category_scores_gemma":[0.0005269538,0.0001941956,0.0002726021,0.001221032,0.000213954,0.000403077,0.0001705102,0.0006826298,0.00000671446],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002800008,"about_ca_system_score_gemma":0.008100257,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.009046166,"about_ca_topic_score_gemma":0.04403757,"domain_scores_codex":[0.9955435,0.0001746154,0.001103318,0.0003149281,0.002415582,0.0004480844],"domain_scores_gemma":[0.9970784,0.0002014662,0.0007992462,0.0002566278,0.001440372,0.0002239248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002156753,0.003040153,0.945497,0.0001801438,0.001849262,0.0002792395,0.005365355,0.02415099,0.002272978,0.0002658492,0.0099473,0.004994966],"study_design_scores_gemma":[0.0122853,0.0004606925,0.9718565,0.000969216,0.0002319789,0.0004301315,0.000517421,0.0002977243,0.002288007,0.0001886457,0.01021495,0.00025942],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990851,0.001295563,0.00001235509,0.002839168,0.002439458,0.0008051525,0.0002830413,0.000009847275,0.001464398],"genre_scores_gemma":[0.9946703,0.001525578,0.0001023318,0.0006853543,0.001482626,0.00007476049,0.000004804207,0.00003911332,0.00141515],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0349914,"threshold_uncertainty_score":0.9999712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063662864","doi":"10.1038/ng.2532","title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":728,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Biology; Aneuploidy; Cancer research; Bruton's tyrosine kinase; Exome sequencing; Receptor tyrosine kinase; Genetics; Signal transduction; Leukemia; Exome; Tyrosine kinase; Gene; Chromosome; Mutation","retraction":null,"screen_n_in":null,"score":{"opus":0.006995370297557125,"gpt":0.2575525198971469,"spread":0.2505571495995897,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001912055,0.000231221,0.0003387243,0.0001155351,0.0001409008,0.00004950634,0.0004749087,0.0004797571,0.0001876195],"category_scores_gemma":[0.0002714371,0.0001444778,0.0001398517,0.0003494481,0.0002596464,0.00003759659,0.0002262253,0.0006749755,0.000385747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005579745,"about_ca_system_score_gemma":0.001295008,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002110904,"about_ca_topic_score_gemma":0.000005945501,"domain_scores_codex":[0.9979721,0.00004714659,0.0003990747,0.0003182683,0.0007042166,0.0005592277],"domain_scores_gemma":[0.9979496,0.0004186523,0.0001313951,0.0008005585,0.0004543317,0.0002454432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001449174,0.0003355325,0.06058211,0.0005229285,0.002599776,0.0002551651,0.0008673489,0.0005150527,0.5102944,0.000919889,0.3434609,0.07819772],"study_design_scores_gemma":[0.01544247,0.00218885,0.6933635,0.0002734759,0.001398081,0.001610142,0.0006365695,0.05933859,0.1225658,0.002683962,0.09941161,0.001086911],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876239,0.005473507,0.0001611728,0.0008426987,0.0004035674,0.0006960533,0.00002077322,0.00005234539,0.004725992],"genre_scores_gemma":[0.992124,0.001435813,0.002592697,0.0005909579,0.0004335522,0.00004327965,0.00002383853,0.0000592688,0.002696556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6327814,"threshold_uncertainty_score":0.5891634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1994568187","doi":"10.1016/j.ccr.2012.06.005","title":"Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia","year":2012,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":718,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Medical Research Council; Stand Up To Cancer; Stanford Bio-X; Michael Smith Health Research BC; U.S. Public Health Service; National Institutes of Health; National Health and Medical Research Council; Haematology Society of Australia and New Zealand; Canadian Institutes of Health Research; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital; Children’s Oncology Group; Bristol-Myers Squibb","keywords":"PDGFRB; Cancer research; Biology; Tyrosine kinase; Receptor tyrosine kinase; Signal transduction; ABL; Bruton's tyrosine kinase; Fms-Like Tyrosine Kinase 3; Leukemia; Gene expression profiling; Gene; Genetics; Mutation; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.0132721938011929,"gpt":0.2719726683335887,"spread":0.2587004745323958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002230123,0.0002398547,0.0003458968,0.0001422964,0.0001376996,0.00003665247,0.0001045034,0.0001385833,0.000560855],"category_scores_gemma":[0.0001443618,0.0002175017,0.00004788049,0.0003380852,0.00009853285,0.0002411347,0.0001057689,0.0003117342,0.00005691912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003382713,"about_ca_system_score_gemma":0.0008675465,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00224063,"about_ca_topic_score_gemma":0.00007764357,"domain_scores_codex":[0.9981599,0.00009133938,0.0003630651,0.000365555,0.0003354133,0.0006847381],"domain_scores_gemma":[0.9987593,0.0003310447,0.0001292628,0.000291441,0.000093833,0.0003950763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004980337,0.0002090114,0.1270152,0.0003548375,0.0001695702,0.00008701242,0.002319837,0.001560634,0.8453842,0.00005039462,0.002316075,0.02003515],"study_design_scores_gemma":[0.02433273,0.0008375804,0.1673712,0.001192758,0.0008287591,0.0001881453,0.001094193,0.03554872,0.759889,0.00009844147,0.007336201,0.001282297],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948648,0.002072482,0.001600626,0.0001262087,0.0002691756,0.000444971,0.00006349802,0.00004936399,0.0005088615],"genre_scores_gemma":[0.9905264,0.001287416,0.006287991,0.000261604,0.0008433568,0.0001564087,0.0000288681,0.00006182867,0.0005461639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08549523,"threshold_uncertainty_score":0.8869464,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2909547032","doi":"10.1038/s41588-018-0315-5","title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","year":2019,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":617,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Biology; Lymphoblastic Leukemia; Progenitor; Progenitor cell; Cancer research; Computational biology; Leukemia; Genetics; Immunology; Stem cell","retraction":null,"screen_n_in":null,"score":{"opus":0.007594102956109199,"gpt":0.2752086812998694,"spread":0.2676145783437602,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001393532,0.0002733214,0.0005283818,0.0002128997,0.00003848873,0.00001709355,0.000374855,0.0007436228,0.000342839],"category_scores_gemma":[0.0001677514,0.0002263856,0.0001888482,0.0004793721,0.0001517767,0.00004239741,0.0002008426,0.0006878171,0.0005024315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008169551,"about_ca_system_score_gemma":0.001748772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000106132,"about_ca_topic_score_gemma":0.00000331197,"domain_scores_codex":[0.9976109,0.00004464286,0.0003953238,0.0004664912,0.0009574118,0.0005252434],"domain_scores_gemma":[0.9980988,0.0001891821,0.0001423936,0.000832808,0.0004710281,0.0002657958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002556045,0.0003254335,0.4628491,0.001399265,0.002009299,0.0005218684,0.0006099869,0.000663293,0.4925309,0.0005555026,0.0250548,0.01092444],"study_design_scores_gemma":[0.01898544,0.003618738,0.2480498,0.0006842029,0.001697068,0.001233573,0.0002620446,0.03762014,0.6466168,0.0004053926,0.03965008,0.001176705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931725,0.001779832,0.0001587244,0.0001774769,0.0007210739,0.0006908125,0.00005470539,0.00006821589,0.003176711],"genre_scores_gemma":[0.9893253,0.0003412009,0.006614458,0.0004084753,0.0004505959,0.00001303669,0.00005728207,0.00007417591,0.002715478],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2147993,"threshold_uncertainty_score":0.9231737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053948474","doi":"10.1053/gast.2002.32420","title":"6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease","year":2002,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":485,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Azathioprine; Inflammatory bowel disease; Internal medicine; Metabolite; Gastroenterology; Adverse effect; Mercaptopurine; Pharmacology; Active metabolite; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.008396415575857375,"gpt":0.2287738953910372,"spread":0.2203774798151798,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001344435,0.000185619,0.0002860436,0.0002231503,0.00003777257,0.00001137477,0.0001341212,0.00008211777,0.00004213537],"category_scores_gemma":[0.0002880579,0.0001490407,0.0000580155,0.0001020303,0.0001679679,0.0001126607,0.00005272796,0.0001754769,0.00001673226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003317356,"about_ca_system_score_gemma":0.00009285283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003279027,"about_ca_topic_score_gemma":0.00002682769,"domain_scores_codex":[0.9982332,0.00007707818,0.0003335556,0.0004296041,0.0003416924,0.0005848697],"domain_scores_gemma":[0.9990824,0.00006785637,0.0001047204,0.0003144827,0.0001763623,0.0002541295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0154815,0.0004831124,0.9757368,0.0003058964,0.00007168262,0.00006100885,0.0001567629,0.000005182829,0.0004258524,0.00009465857,0.007051793,0.0001257607],"study_design_scores_gemma":[0.0168066,0.000892584,0.9786456,0.0001244557,0.00008436307,0.000006842845,0.00002223533,0.001425407,0.0002674054,0.00007247017,0.001542373,0.0001096505],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954381,0.0001322517,0.0008424827,0.001876551,0.0000492244,0.001462311,0.00009428382,0.00004427444,0.00006051644],"genre_scores_gemma":[0.9951496,0.00001175683,0.002800865,0.0007149237,0.00009871089,0.0005952527,0.0002360924,0.00003503578,0.0003577498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00550942,"threshold_uncertainty_score":0.6077703,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092925278","doi":"10.1182/blood-2006-01-024729","title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":476,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Concordance; Oncology; Minimal residual disease; Cog; Cancer; Acute lymphocytic leukemia; White blood cell; Hematology; Leukemia; Pediatrics; Lymphoblastic Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.006805720420293499,"gpt":0.248935339241957,"spread":0.2421296188216635,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007676078,0.0003151099,0.0008926633,0.0005834667,0.0001393247,0.00002429075,0.0002501145,0.0003010119,0.0000512324],"category_scores_gemma":[0.0008772807,0.0002314905,0.0001959951,0.001637721,0.0005168514,0.00006820944,0.0001193649,0.0003285393,0.000001975451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004810174,"about_ca_system_score_gemma":0.001332613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003794031,"about_ca_topic_score_gemma":0.000534651,"domain_scores_codex":[0.9969811,0.0006234102,0.0007324377,0.0006267992,0.0006192476,0.0004169969],"domain_scores_gemma":[0.9943034,0.004077738,0.0006593468,0.0005800395,0.0001999897,0.0001795101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005407532,0.001385412,0.9822913,0.00006341892,0.003349026,0.00002504662,0.0002276592,0.00005532354,0.005352352,0.00004880959,0.000271363,0.001522799],"study_design_scores_gemma":[0.0174388,0.001737025,0.9467509,0.00006315815,0.02578564,0.0000259158,0.00008374421,0.007444602,0.0004069397,0.00006696893,0.000009098148,0.0001872462],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952711,0.001542579,0.0005460263,0.0004242914,0.00004172651,0.001293565,0.00077917,0.00004585004,0.00005564564],"genre_scores_gemma":[0.9975603,0.0005885632,0.001011485,0.0000780936,0.0001458354,0.0001923808,0.0003599425,0.00004416855,0.00001919202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03554039,"threshold_uncertainty_score":0.9439907,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008271309","doi":"10.1038/nature09733","title":"Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells","year":2011,"lang":"en","type":"article","venue":"Nature","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":457,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"CDKN2B; CDKN2A; Biology; clone (Java method); Somatic evolution in cancer; Cancer research; Genetics; Immunology; DNA; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0208715634215344,"gpt":0.2880414438224468,"spread":0.2671698804009124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002788316,0.0001911142,0.0003501939,0.0002423188,0.0000979664,0.000007533075,0.0002269303,0.001219605,0.0005562634],"category_scores_gemma":[0.0004202485,0.0001623397,0.0001268303,0.0004242416,0.0001583111,0.0001052562,0.0001098952,0.001516161,0.0001194653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001087621,"about_ca_system_score_gemma":0.0006976211,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001943279,"about_ca_topic_score_gemma":0.00001072373,"domain_scores_codex":[0.9981851,0.00005800772,0.0003561752,0.0003244886,0.0006552955,0.0004209565],"domain_scores_gemma":[0.9987059,0.0001531436,0.00015763,0.0004435264,0.0003548564,0.0001849508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009323187,0.0008002487,0.03770258,0.00127386,0.000324046,0.0005189686,0.002600366,0.00001734981,0.9113255,0.01383675,0.02851331,0.002154707],"study_design_scores_gemma":[0.01155362,0.002176492,0.1277128,0.001283203,0.0005207164,0.0004341427,0.00130323,0.004420009,0.8452339,0.00312418,0.001516373,0.0007214198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9492536,0.0006036258,0.0006067312,0.00006464522,0.0003242035,0.0003749082,0.00002286517,0.0001128892,0.0486366],"genre_scores_gemma":[0.9961857,0.0000108973,0.002190054,0.0002579579,0.000287625,0.00001136687,0.00002093972,0.00004240939,0.0009930771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0900102,"threshold_uncertainty_score":0.9406713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047597898","doi":"10.1038/leu.2014.30","title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":449,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nova Scotia Cancer Centre; BC Children's Hospital; University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Minimal residual disease; Imatinib; Internal medicine; Chemotherapy; Cohort; Imatinib mesylate; Acute lymphocytic leukemia; Oncology; Induction chemotherapy; Philadelphia chromosome; Leukemia; Lymphoblastic Leukemia; Chromosomal translocation; Myeloid leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.01199791892873685,"gpt":0.2883121082159874,"spread":0.2763141892872505,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001187477,0.0008378247,0.002003513,0.001164828,0.0001704172,0.00005094275,0.0009244169,0.0007594689,0.0002448302],"category_scores_gemma":[0.0008436455,0.0007614361,0.0003885253,0.001841621,0.0004334864,0.0003262167,0.0006467639,0.001275619,0.0003016249],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0122915,"about_ca_system_score_gemma":0.004580934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000704061,"about_ca_topic_score_gemma":0.0003179992,"domain_scores_codex":[0.9932165,0.0006317437,0.001693643,0.001398474,0.001556319,0.00150337],"domain_scores_gemma":[0.9956129,0.001348041,0.0006536177,0.001342019,0.0003946368,0.0006487541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005207927,0.00288122,0.9620854,0.0007687866,0.001573086,0.002500013,0.003805265,0.0002838474,0.008932625,0.0003712643,0.003288053,0.008302464],"study_design_scores_gemma":[0.04661838,0.007512501,0.9379175,0.0002984786,0.001510774,0.0009093565,0.0002026235,0.003031942,0.001127836,0.0001023409,0.0000279525,0.0007402649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923341,0.0001982466,0.001075378,0.0002704103,0.0005700403,0.002739246,0.0000666611,0.0001796209,0.002566317],"genre_scores_gemma":[0.9964925,0.0002599061,0.0006177981,0.000427704,0.001063347,0.0002723449,0.0002851851,0.0001819322,0.0003992644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04141046,"threshold_uncertainty_score":0.9994836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137147070","doi":"10.1186/gb-2013-14-9-r105","title":"Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Genome biology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"Uppsala Multidisciplinary Center for Advanced Computational Science; Stiftelsen för Strategisk Forskning; Barncancerfonden; Cancerfonden; Svenska Forskningsrådet Formas; Vetenskapsrådet","keywords":"Biology; Genome Biology; Human genetics; DNA methylation; Lymphoblastic Leukemia; Genome; Computational biology; Genetics; Genomics; Methylation; Human genome; DNA; Evolutionary biology; Gene; Leukemia; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.01129747235375721,"gpt":0.2623608278675856,"spread":0.2510633555138284,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002017409,0.0002707178,0.0006516114,0.0007217738,0.00004342474,0.00001243546,0.0002980126,0.0004444249,0.001067929],"category_scores_gemma":[0.0003273202,0.0002177514,0.0001317572,0.0005746235,0.0001988552,0.00007904832,0.0002105846,0.0003169249,0.0003270573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001154501,"about_ca_system_score_gemma":0.0008323334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000205012,"about_ca_topic_score_gemma":0.00001343547,"domain_scores_codex":[0.9977669,0.0001690849,0.0006354514,0.000496114,0.0002610686,0.0006713719],"domain_scores_gemma":[0.9984753,0.0005013152,0.0001933724,0.0004165604,0.0002041369,0.0002093711],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0004284324,0.0001283148,0.05518999,0.0001662736,0.0002019263,0.00004384626,0.0002528466,0.00009985775,0.9419064,0.0001365738,0.0001801897,0.001265344],"study_design_scores_gemma":[0.003887862,0.0008359614,0.9880607,0.00001196493,0.0001837987,0.00003038628,0.00003518956,0.001138372,0.004501085,0.0007304269,0.0003393711,0.0002449114],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950112,0.0007663763,0.0021247,0.0002106513,0.0001965861,0.0007916898,0.0000298123,0.00004607846,0.0008229634],"genre_scores_gemma":[0.9976608,0.0004361731,0.0005384184,0.0001549742,0.0004173187,0.00009292238,0.0002555157,0.0000390319,0.0004048129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9374053,"threshold_uncertainty_score":0.9998452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017265604","doi":"10.1182/blood-2006-06-027714","title":"Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Centre hospitalier universitaire de Québec; Université de Montréal","funders":"National Institutes of Health; National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Medicine; Dexrazoxane; Asparaginase; Internal medicine; Chemotherapy; Surgery; Cancer; Leukemia; Pediatrics; Lymphoblastic Leukemia; Breast cancer; Anthracycline","retraction":null,"screen_n_in":null,"score":{"opus":0.01381814606676685,"gpt":0.2898975574202851,"spread":0.2760794113535183,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002203665,0.0003177077,0.0005021991,0.00009048106,0.0001268938,0.00002731272,0.0004005378,0.0001782576,0.00002610354],"category_scores_gemma":[0.0001862208,0.0001866916,0.0001606124,0.0004193984,0.000527179,0.0001153209,0.0001451954,0.0002231561,0.000009680108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006601018,"about_ca_system_score_gemma":0.004167513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002908315,"about_ca_topic_score_gemma":0.0007354404,"domain_scores_codex":[0.997443,0.00004668792,0.000604606,0.0005317615,0.0007473537,0.0006266591],"domain_scores_gemma":[0.9982452,0.0001433923,0.0003208044,0.0008168097,0.0003136551,0.0001601449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.05068694,0.009394481,0.3379883,0.003051,0.0172742,0.0008342035,0.0009983353,0.004233325,0.1410841,0.003965513,0.4263285,0.004161088],"study_design_scores_gemma":[0.2349758,0.003267555,0.3294553,0.001599897,0.006232166,0.002116423,0.00003826588,0.002198629,0.3442274,0.0002927251,0.07446877,0.001127029],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8892406,0.00006352795,0.0005451362,0.001123563,0.0001544485,0.1025947,0.0007601697,0.0001330593,0.005384795],"genre_scores_gemma":[0.8974816,0.00001513307,0.003262274,0.0006898721,0.000932291,0.09118655,0.0001945749,0.0001467888,0.006090922],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3518597,"threshold_uncertainty_score":0.7613063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151645052","doi":"10.1038/ng.2754","title":"A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Health and Medical Research Council; KWF Kankerbestrijding; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Geoffrey Beene Cancer Research Center; American Lebanese Syrian Associated Charities; National Institute of General Medical Sciences; Medical Research Council; Deutsche Forschungsgemeinschaft; St. Jude Children's Research Hospital","keywords":"Biology; PAX5; Loss of heterozygosity; Germline; Germline mutation; Genetics; Mutation; Allele; Molecular biology; B cell; Somatic cell; Cancer research; Gene; Transcription factor; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.009473553381522998,"gpt":0.2931197454918782,"spread":0.2836461921103552,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002780948,0.0004045684,0.0004903835,0.000259492,0.0001062381,0.00008494701,0.0003605567,0.0007291611,0.0006311262],"category_scores_gemma":[0.0005124124,0.0003451846,0.000162523,0.0006184534,0.0001492775,0.00008389849,0.0002333767,0.0009651477,0.0009448614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002566941,"about_ca_system_score_gemma":0.001833739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008844721,"about_ca_topic_score_gemma":0.00003776736,"domain_scores_codex":[0.9966226,0.00009992473,0.0005672163,0.0008134798,0.001087128,0.0008096769],"domain_scores_gemma":[0.9969213,0.0002445709,0.0001308686,0.0009323059,0.0009822786,0.0007886647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005000787,0.001687429,0.03300292,0.00240761,0.001204437,0.0009992658,0.005570712,0.003104184,0.4125735,0.0001451005,0.3617575,0.1725466],"study_design_scores_gemma":[0.02598623,0.008912947,0.5390075,0.0006874392,0.001703586,0.0009913092,0.0007176167,0.1343007,0.2508489,0.001257061,0.03315454,0.002432087],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897208,0.000705377,0.003697095,0.001203169,0.0006596623,0.002301341,0.00006479107,0.0001430763,0.001504642],"genre_scores_gemma":[0.9831799,0.0001632217,0.01155674,0.001904971,0.0005252,0.0001498849,0.0001982038,0.00008039596,0.002241533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5060046,"threshold_uncertainty_score":0.9999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052739233","doi":"10.1038/leu.2014.229","title":"Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Hôpital Maisonneuve-Rosemont; Alberta Cancer Foundation; Hamilton Health Sciences; Dalhousie University; CancerCare Manitoba; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Regimen; Young adult; Confidence interval; Pediatrics; Internal medicine; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.01821218232353751,"gpt":0.2860786902423308,"spread":0.2678665079187933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006673695,0.0006944834,0.001479901,0.0005655007,0.0001577123,0.00006947729,0.000746051,0.0005196862,0.0001440575],"category_scores_gemma":[0.001033217,0.0005826006,0.0004171415,0.000844644,0.0003522528,0.00025151,0.0002222392,0.0005320331,0.0001401724],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004901753,"about_ca_system_score_gemma":0.003456619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005298445,"about_ca_topic_score_gemma":0.000172842,"domain_scores_codex":[0.9947857,0.0001623252,0.001182537,0.001118123,0.001421027,0.001330306],"domain_scores_gemma":[0.9949756,0.001731718,0.0006229546,0.001502209,0.0004161739,0.0007513575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02634196,0.0007577465,0.9016852,0.004942333,0.002402467,0.002512476,0.003855272,0.0009177973,0.01997554,0.0004419196,0.02663998,0.009527303],"study_design_scores_gemma":[0.1233121,0.005648293,0.8451903,0.00110443,0.003291923,0.0004846417,0.0002097437,0.01317224,0.004996987,0.0001138518,0.0008703464,0.001605089],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985092,0.00009780452,0.01098155,0.0001644375,0.0002746143,0.002398182,0.0001052081,0.0002981271,0.0005880085],"genre_scores_gemma":[0.9883067,0.00008091462,0.007215102,0.0004901248,0.0009991939,0.0004044016,0.0002425874,0.0002515713,0.002009388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09697016,"threshold_uncertainty_score":0.9996625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2535017817","doi":"10.1038/ng.3691","title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health","keywords":"Erg; Biology; Transactivation; ETS transcription factor family; Transcription factor; Gene isoform; Transcription (linguistics); Cancer research; Molecular biology; Exon; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.008064641672652197,"gpt":0.276440814094796,"spread":0.2683761724221438,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001469921,0.0001376694,0.0002585888,0.0002072496,0.0000188564,0.00000597808,0.00009835361,0.0004221988,0.00004885116],"category_scores_gemma":[0.0002785751,0.0000914608,0.00003780548,0.000274866,0.0001551757,0.00003861608,0.00009049265,0.0002024153,0.00001184516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006285304,"about_ca_system_score_gemma":0.0006010833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009008737,"about_ca_topic_score_gemma":0.0000145027,"domain_scores_codex":[0.9987426,0.00003104696,0.0002670142,0.0002657284,0.0004206169,0.0002730213],"domain_scores_gemma":[0.9991221,0.0002112124,0.00006927645,0.000311499,0.0001574696,0.000128423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001720096,0.0001675537,0.3116181,0.0004307415,0.0003198325,0.0003171613,0.0004765848,0.0000758395,0.5158646,0.0007816031,0.00592692,0.1623009],"study_design_scores_gemma":[0.009737783,0.000481174,0.8457327,0.0004662943,0.0001645353,0.0003142724,0.00002747256,0.004540948,0.1350109,0.001133127,0.002157937,0.0002328155],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959261,0.001275508,0.001053004,0.0006424455,0.0001099081,0.0002536698,0.00001558327,0.00001977278,0.0007039662],"genre_scores_gemma":[0.9946419,0.0006299916,0.003719541,0.0001747646,0.0001100196,0.000006728441,0.000006819128,0.00002619826,0.000684057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5341146,"threshold_uncertainty_score":0.3729663,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008312111","doi":"10.1182/blood-2005-06-2448","title":"A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"NIH Clinical Center","keywords":"Leukemia; Medicine; Trisomy; Down syndrome; Incidence (geometry); Acute leukemia; White blood cell; Aneuploidy; Internal medicine; Prospective cohort study; Gastroenterology; Pediatrics; Immunology; Biology; Chromosome","retraction":null,"screen_n_in":null,"score":{"opus":0.006028763279400138,"gpt":0.2317640146587528,"spread":0.2257352513793527,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003612249,0.0002709904,0.0007803856,0.0002763108,0.00004251002,0.000004329493,0.000353212,0.0001193361,0.00002729856],"category_scores_gemma":[0.00006786788,0.0001673727,0.00009650618,0.0005960987,0.0003608337,0.00007004879,0.0001210055,0.0006004105,0.00000241992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002773795,"about_ca_system_score_gemma":0.001821574,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009008536,"about_ca_topic_score_gemma":0.004629363,"domain_scores_codex":[0.9973026,0.0002650265,0.0005896655,0.0005071622,0.0009231991,0.0004123683],"domain_scores_gemma":[0.9987296,0.000186535,0.0002344942,0.0005780582,0.0001967695,0.00007448393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002240744,0.02903787,0.9493377,0.0001049556,0.001164635,0.001071439,0.0122253,0.00008355637,0.004125701,0.00005688248,0.0002407585,0.0003104949],"study_design_scores_gemma":[0.04164763,0.01326561,0.9403033,0.0001237417,0.0008229425,0.0007089967,0.002457631,0.0000461103,0.0004238275,0.00001681774,0.00002561929,0.0001577989],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933098,0.0007691152,0.000002269962,0.00006313957,0.0001029195,0.004697956,0.000009703601,0.00003196813,0.001013104],"genre_scores_gemma":[0.9990473,0.000003260079,0.00009732155,0.00002872351,0.00004562392,0.0002214425,0.000007484273,0.00003977688,0.0005090969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03940688,"threshold_uncertainty_score":0.9975905,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1972467214","doi":"10.1038/leu.2009.253","title":"Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Vincristine; Chemotherapy; Asparaginase; Cancer; Internal medicine; Acute lymphocytic leukemia; Pediatrics; Clinical trial; Surgery; Leukemia; Lymphoblastic Leukemia; Cyclophosphamide","retraction":null,"screen_n_in":null,"score":{"opus":0.02372343446026951,"gpt":0.3262741725191292,"spread":0.3025507380588596,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004327193,0.0008110474,0.00138703,0.0004203421,0.0001897621,0.00009133848,0.0007746557,0.0005244486,0.00007750688],"category_scores_gemma":[0.0005403974,0.0006342902,0.0003266135,0.0008204313,0.0006777775,0.000451582,0.0001415084,0.0005884483,0.00005471765],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.0090531,"about_ca_system_score_gemma":0.01427241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001445918,"about_ca_topic_score_gemma":0.0004771451,"domain_scores_codex":[0.9944847,0.00008775797,0.001339556,0.001292691,0.001313836,0.001481428],"domain_scores_gemma":[0.9959986,0.0003996231,0.0006636875,0.001490987,0.000687053,0.0007601032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1550549,0.003993458,0.2724283,0.004297953,0.01635792,0.007646265,0.005928987,0.0187009,0.1197536,0.002348029,0.2237713,0.1697184],"study_design_scores_gemma":[0.1383103,0.007795238,0.7940944,0.003763782,0.00269381,0.001389405,0.00003991594,0.004922247,0.03673897,0.0001723834,0.008269753,0.001809777],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9559283,0.0001573228,0.004371057,0.001235618,0.0002286888,0.03442824,0.000805778,0.0003322653,0.002512712],"genre_scores_gemma":[0.9710331,0.0002144278,0.006134881,0.002898356,0.001028916,0.01220284,0.001022899,0.0002107459,0.005253853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5216661,"threshold_uncertainty_score":0.9996108,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973054937","doi":"10.1038/ni1314","title":"Early hematopoietic lineage restrictions directed by Ikaros","year":2006,"lang":"en","type":"article","venue":"Nature Immunology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Myeloid; Biology; Haematopoiesis; Progenitor cell; Progenitor; Cell biology; Lineage (genetic); Immunology; Stem cell; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.004424938756049553,"gpt":0.2598872367901726,"spread":0.255462298034123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001035864,0.0001976334,0.0003498846,0.0002426683,0.0001392286,0.00002078622,0.0002047125,0.0009728014,0.0002053049],"category_scores_gemma":[0.0003618065,0.0001681197,0.0001016905,0.0006898163,0.0002357225,0.00006041247,0.00009042087,0.001586488,0.0003286186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005112853,"about_ca_system_score_gemma":0.000304085,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005800204,"about_ca_topic_score_gemma":0.00001762701,"domain_scores_codex":[0.9983913,0.0000847869,0.000311596,0.0003663627,0.0003227502,0.0005232004],"domain_scores_gemma":[0.9988226,0.0002709092,0.00007670785,0.0005232751,0.000226382,0.00008016081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007032505,0.0007192082,0.007703825,0.00005777012,0.0003496678,0.0005688246,0.0001186223,0.000002141383,0.403634,0.003741781,0.5812716,0.00112934],"study_design_scores_gemma":[0.01423359,0.001519816,0.2806705,0.0001759649,0.0003359103,0.003124493,0.0001201714,0.0004989261,0.1574744,0.001071192,0.5400179,0.0007572091],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9661382,0.01171369,0.0003671638,0.005218719,0.0006447211,0.0005654983,0.00004670654,0.0006733224,0.01463192],"genre_scores_gemma":[0.9831496,0.0001379801,0.0008571305,0.0004836571,0.000303454,0.000048955,0.0001915138,0.00004725312,0.01478047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2729667,"threshold_uncertainty_score":0.7503135,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028865791","doi":"10.1002/cncr.23205","title":"Childhood cancer epidemiology in low‐income countries","year":2007,"lang":"en","type":"review","venue":"Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":300,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Pediatric Oncology Group of Ontario; American Lebanese Syrian Associated Charities","keywords":"Medicine; Ethnic group; Epidemiology; Childhood leukemia; Cancer; Incidence (geometry); Etiology; Family medicine; Pediatric cancer; Pediatrics; Intensive care medicine; Environmental health; Pathology; Leukemia; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07630326863626341,"gpt":0.4507451684525967,"spread":0.3744418998163333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001138828,0.0005865952,0.003804588,0.0005957523,0.00005224105,0.000009900112,0.0003961825,0.0009758367,0.00236617],"category_scores_gemma":[0.0007309283,0.0004272988,0.0004338091,0.0006993227,0.0003665925,0.00005464932,0.000174997,0.001375376,0.0005190168],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007643074,"about_ca_system_score_gemma":0.009281968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001469434,"about_ca_topic_score_gemma":0.0004802025,"domain_scores_codex":[0.9961233,0.0002482108,0.001235119,0.0008005921,0.0004171627,0.001175585],"domain_scores_gemma":[0.9967089,0.001704849,0.0003838317,0.0006780121,0.0001605295,0.0003639259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007009743,0.0000653653,0.00301682,0.05158902,0.0005023165,0.0004328911,0.00009313186,0.000007311796,4.015769e-8,0.0001959774,0.01412949,0.9298975],"study_design_scores_gemma":[0.001193136,0.00005340691,0.001036544,0.06692106,0.0005049171,0.0001092993,0.000004878847,0.00001494978,6.953117e-7,0.00002863077,0.9297907,0.0003418095],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003245351,0.9953763,0.00003364653,0.0007164406,0.001064152,0.001485767,0.000233703,0.00006074814,0.0009968162],"genre_scores_gemma":[0.00001610646,0.991244,0.0001017721,0.001603598,0.002078682,0.001072173,0.00009512307,0.0001363527,0.003652178],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9295557,"threshold_uncertainty_score":0.9998179,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2553214673","doi":"10.1038/ncomms13331","title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia","year":2016,"lang":"en","type":"article","venue":"Nature Communications","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":296,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of General Medical Sciences; Stand Up To Cancer; U.S. Department of Health and Human Services; National Institutes of Health; ECOG-ACRIN Cancer Research Group; American College of Radiology Imaging Network; American Lebanese Syrian Associated Charities; Leukemia and Lymphoma Society; Alex's Lemonade Stand Foundation for Childhood Cancer; St. Jude Children's Research Hospital; National Cancer Institute; Cancer Research UK","keywords":"Biology; Immunophenotyping; Enhancer; Gene rearrangement; Genetics; Gene; Cancer research; Gene expression; Flow cytometry","retraction":null,"screen_n_in":null,"score":{"opus":0.05398337816325051,"gpt":0.4089958153854702,"spread":0.3550124372222197,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003698423,0.0002381667,0.0004115552,0.0005990721,0.0002318485,0.000035501,0.001344141,0.0004380097,0.0002259018],"category_scores_gemma":[0.001192125,0.0001618751,0.0001742601,0.001010309,0.0003672127,0.0001563695,0.00101526,0.001010156,0.0004690506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002162735,"about_ca_system_score_gemma":0.001088457,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007937731,"about_ca_topic_score_gemma":0.0007447947,"domain_scores_codex":[0.9978499,0.0002442135,0.0005285988,0.0004046281,0.0004915172,0.000481161],"domain_scores_gemma":[0.9949706,0.001325364,0.0001347857,0.00298712,0.0003129118,0.0002692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000986923,0.001949648,0.1289434,0.0001186686,0.001398449,0.0002785183,0.001012784,0.00001438147,0.7193877,0.01023914,0.0829566,0.05271382],"study_design_scores_gemma":[0.01088826,0.0003496897,0.8995718,0.0012939,0.0009679577,0.0005496086,0.0002735107,0.003515485,0.005902025,0.001333214,0.07458708,0.0007674777],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422145,0.01227288,0.001243607,0.03202703,0.0004751294,0.001274691,0.0002074454,0.0002765782,0.01000818],"genre_scores_gemma":[0.9884512,0.005257241,0.00422143,0.0005242533,0.00008116551,0.0001287393,0.0001187723,0.00004401453,0.001173131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7706283,"threshold_uncertainty_score":0.6601076,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113030986","doi":"10.1056/nejmoa1110169","title":"Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre","funders":"Assistance publique-Hôpitaux de Paris; Barncancerfonden; Deutsche Krebshilfe; National Cancer Institute; Cancer Research UK; American Lebanese Syrian Associated Charities; Massachusetts Medical Society; Institut National de la Santé et de la Recherche Médicale; St. Jude Children's Research Hospital; Medical Research Council; Cancer Research Institute","keywords":"Medicine; Lymphoblastic Leukemia; Adverse effect; Induction therapy; Pediatrics; Leukemia; Oncology; Internal medicine; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01230725484116841,"gpt":0.2798578675395093,"spread":0.2675506126983409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001210974,0.0002678577,0.0008354504,0.0007194019,0.00003344648,0.00001001272,0.0001739486,0.000187248,0.0006548936],"category_scores_gemma":[0.001143948,0.0001617037,0.0001230729,0.0004797242,0.0001442372,0.0003616076,0.00005267869,0.0008171767,0.00004528871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001280824,"about_ca_system_score_gemma":0.001186513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001165381,"about_ca_topic_score_gemma":0.00003848396,"domain_scores_codex":[0.997189,0.0001207773,0.0008403002,0.0001665277,0.001093574,0.0005898583],"domain_scores_gemma":[0.9980428,0.0003649456,0.0002914451,0.000263446,0.0002025486,0.0008348206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004613071,0.0004648115,0.8563344,0.0001185136,0.0008587578,0.002297674,0.008471367,0.00003928582,0.005049403,0.0001102972,0.02688919,0.09475324],"study_design_scores_gemma":[0.1072918,0.001288757,0.8607202,0.0008561996,0.0005666665,0.01371754,0.0004685019,0.00005059217,0.0003580255,0.0001849957,0.01430925,0.0001874107],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9858771,0.0009764596,0.0007019374,0.01050989,0.001038289,0.0002237153,0.000002193548,0.00001789794,0.000652517],"genre_scores_gemma":[0.9898569,0.0002266712,0.001167688,0.001084816,0.006924226,0.000004900307,0.000006529117,0.00003908286,0.0006891778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1026788,"threshold_uncertainty_score":0.7170625,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162051878","doi":"10.1002/cncr.11042","title":"A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L‐asparaginase","year":2003,"lang":"en","type":"article","venue":"Cancer","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Canadian Institutes of Health Research","funders":"Canadian Institutes of Health Research; Bayer Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Venography; Pediatrics; Prospective cohort study; Population; Internal medicine; Cohort; Surgery; Thrombosis","retraction":null,"screen_n_in":null,"score":{"opus":0.009397771798545406,"gpt":0.2710604830452278,"spread":0.2616627112466824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001460201,0.0002641878,0.0005612706,0.00009853823,0.00007959959,0.00001158388,0.0001365238,0.00005944636,0.00002956218],"category_scores_gemma":[0.00009992504,0.0001504122,0.00002533313,0.0005089727,0.0002819223,0.00008951857,0.00004247776,0.0002361669,0.000001318903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001805054,"about_ca_system_score_gemma":0.001488385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004713836,"about_ca_topic_score_gemma":0.000246632,"domain_scores_codex":[0.9981439,0.000115395,0.0002453903,0.0005021375,0.0005107445,0.0004824263],"domain_scores_gemma":[0.9990247,0.00009188602,0.0001617615,0.000376852,0.0001929077,0.0001518956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00103818,0.0004749801,0.9957592,0.0001411699,0.0007502021,0.0001478835,0.001180182,0.0003228589,0.00004838106,0.000002922346,0.000008791284,0.0001252271],"study_design_scores_gemma":[0.01199739,0.002817051,0.9809301,0.0009369581,0.001063918,0.0003255493,0.0002144157,0.0008746146,0.0006664131,0.000004208463,6.812148e-7,0.0001687386],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962157,0.0003108111,0.00004835508,0.00001995795,0.0000145629,0.00326309,0.00003203459,0.00002164333,0.00007387291],"genre_scores_gemma":[0.9989262,0.0001759468,0.00006006937,0.00004398914,0.00003022818,0.0004276204,0.000003730165,0.00004431503,0.0002878724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01482916,"threshold_uncertainty_score":0.613363,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117590220","doi":"10.1634/theoncologist.11-6-590","title":"Cancer in 15- to 29-Year-Olds by Primary Site","year":2006,"lang":"en","type":"review","venue":"The Oncologist","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Ethnic group; Race (biology); Cancer survival; Demography; Quarter (Canadian coin); Incidence (geometry); Cancer; Cancer incidence; Gerontology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0429315510139662,"gpt":0.3956065011842133,"spread":0.3526749501702471,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008378666,0.0004438845,0.001987531,0.0002187791,0.00007253229,0.00003614266,0.0006463529,0.0005462872,0.0004566688],"category_scores_gemma":[0.0002614541,0.0002534666,0.0002825998,0.0009006607,0.0003166406,0.00002976273,0.0004367995,0.001066932,0.001205071],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008618591,"about_ca_system_score_gemma":0.004033627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003141962,"about_ca_topic_score_gemma":0.0008236799,"domain_scores_codex":[0.9970993,0.0003143442,0.000677251,0.0005654998,0.0006277452,0.0007158607],"domain_scores_gemma":[0.9978964,0.0007716692,0.0002117442,0.0008354043,0.00007833407,0.000206493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007611753,0.000128806,0.00008674953,0.003978653,0.00007628042,0.000213797,0.00003046109,0.000003295143,0.000006482178,0.00001523311,0.4990898,0.4962943],"study_design_scores_gemma":[0.00098772,0.0002558128,0.0002017715,0.004792381,0.0004427816,0.00007773814,0.000008624914,0.000006379353,0.000001482985,0.000006932456,0.9929646,0.0002537911],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006075608,0.9580952,0.00002362436,0.001627331,0.000234618,0.002339305,0.0003379068,0.00007116902,0.0372101],"genre_scores_gemma":[0.00001742565,0.9563975,0.0001775686,0.001335371,0.0007158205,0.0007387652,0.000329778,0.00009460095,0.04019312],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4960406,"threshold_uncertainty_score":0.9999918,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W30310674","doi":"10.1182/blood.v95.9.2770.009k16_2770_2775","title":"Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy","year":2000,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Confidence interval; Radiation therapy; Pediatrics; Cumulative incidence; Incidence (geometry); Leukemia; Internal medicine; Surgery; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.007046606866034718,"gpt":0.2486966502289265,"spread":0.2416500433628917,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005412791,0.0005841074,0.001145937,0.0005025956,0.0001016658,0.0000509748,0.0005304617,0.0003679451,0.003569846],"category_scores_gemma":[0.00007220828,0.0004876307,0.0003246741,0.0008643274,0.0002631899,0.0001710177,0.00005724259,0.0006765609,0.0002632273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001180601,"about_ca_system_score_gemma":0.003096235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007590196,"about_ca_topic_score_gemma":0.00009745935,"domain_scores_codex":[0.9958678,0.000237505,0.0009131494,0.0009016859,0.001047864,0.001031946],"domain_scores_gemma":[0.9977328,0.000313816,0.000185285,0.001044452,0.0001588026,0.0005649089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.04968166,0.01334799,0.1738689,0.0004144113,0.01022699,0.005876584,0.02133473,0.00248373,0.4581186,0.00006298507,0.00585768,0.2587257],"study_design_scores_gemma":[0.2396914,0.01594147,0.5665869,0.001348178,0.00157194,0.002962774,0.0003195035,0.004520483,0.1473428,0.0002190453,0.01684504,0.00265051],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994378,0.0006084495,0.0002908795,0.0003217797,0.0002015034,0.001792191,0.0001835732,0.0001107347,0.00211285],"genre_scores_gemma":[0.9906998,0.002420285,0.003388477,0.001385056,0.0004618605,0.0001237466,0.00004612838,0.0001716746,0.001303028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.392718,"threshold_uncertainty_score":0.9997575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052968703","doi":"10.1016/s1470-2045(11)70128-0","title":"Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Scopus; Medicine; Abandonment (legal); Cancer; Family medicine; Pediatrics; MEDLINE; Internal medicine; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.1039594479834797,"gpt":0.3727010462784121,"spread":0.2687415982949323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004173677,0.0001037519,0.0005154986,0.00005185841,0.00003768347,0.000001375794,0.0001262166,0.00006674535,0.0001154956],"category_scores_gemma":[0.00002394506,0.00006133697,0.00008493908,0.00008440831,0.0001205185,0.00001589827,0.00004915097,0.00006974894,0.000002687398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001550685,"about_ca_system_score_gemma":0.0004309953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000773063,"about_ca_topic_score_gemma":0.0001423706,"domain_scores_codex":[0.9989878,0.00008932198,0.0003200484,0.0001536796,0.000156982,0.0002921861],"domain_scores_gemma":[0.9991812,0.0002183155,0.0002094479,0.0002765448,0.00006063042,0.00005393212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.04594027,0.009999206,0.03700535,0.0009486062,0.004508981,0.0001344729,0.08699835,0.00007948835,0.1964268,0.01402019,0.009171598,0.5947667],"study_design_scores_gemma":[0.1374706,0.080615,0.3707207,0.001569367,0.002864167,0.0003411111,0.002727147,0.003408936,0.3224983,0.005574892,0.07158446,0.0006253881],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906536,0.0004279592,0.001164353,0.002901509,0.0001492349,0.00153072,0.00006741246,0.00001953571,0.003085633],"genre_scores_gemma":[0.9945696,0.0008339754,0.003444796,0.0003761841,0.0002564373,0.0003694919,0.00002635154,0.000015031,0.0001081379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5941413,"threshold_uncertainty_score":0.4054989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005615400","doi":"10.1101/gr.129668.111","title":"Rare versus common variants in pharmacogenetics: <i>SLCO1B1</i> variation and methotrexate disposition","year":2011,"lang":"en","type":"article","venue":"Genome Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; McGill University; National Heart, Lung, and Blood Institute; American Lebanese Syrian Associated Charities","keywords":"SLCO1B1; Biology; Pharmacogenetics; Single-nucleotide polymorphism; Pharmacogenomics; Genome-wide association study; Minor allele frequency; Allele frequency; Genetic variation; Genetics; Allele; Genotype; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1227617595572424,"gpt":0.3922522461000728,"spread":0.2694904865428304,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002120409,0.0001596523,0.0002916955,0.0006230976,0.0001478451,0.00004091935,0.0002135644,0.0001568333,0.0005433769],"category_scores_gemma":[0.0002558353,0.0001484088,0.00003996096,0.0008658069,0.0002084588,0.0001406074,0.0002978033,0.0006393899,0.0002078062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000740075,"about_ca_system_score_gemma":0.0004179921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084388,"about_ca_topic_score_gemma":0.00005650287,"domain_scores_codex":[0.996954,0.0005907437,0.0003155849,0.0004781369,0.0009011952,0.0007602875],"domain_scores_gemma":[0.9984544,0.0004633114,0.00004269829,0.0004052715,0.0002844467,0.000349899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02725075,0.001537723,0.03214202,0.00100348,0.0005422501,0.003400679,0.01943593,0.00002770133,0.8606619,0.00168545,0.0009522567,0.05135988],"study_design_scores_gemma":[0.02189424,0.001980491,0.9441748,0.0001802302,0.0001233392,0.0002128577,0.0005849464,0.006627958,0.02080413,0.001464617,0.001538662,0.0004137719],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809974,0.000851139,0.0006666391,0.0004081155,0.0001169383,0.00102003,0.00003882463,0.00004250463,0.0158584],"genre_scores_gemma":[0.995011,0.000935745,0.003204978,0.00006403806,0.0001579238,0.00009218892,0.00006910715,0.00004279119,0.0004221874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9120327,"threshold_uncertainty_score":0.6051934,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016749216","doi":"10.1038/ng.585","title":"Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk","year":2010,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institute of General Medical Sciences; Cancer Research UK; Wellcome Trust","keywords":"CDKN2A; Biology; Odds ratio; Lymphoblastic Leukemia; Leukemia; Genome-wide association study; Genetics; Internal medicine; Oncology; Single-nucleotide polymorphism; Genotype; Gene; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.004749406992555375,"gpt":0.2656496947690676,"spread":0.2609002877765123,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000418296,0.000327073,0.0004100612,0.0003629832,0.000150927,0.00004891821,0.0003883836,0.001179926,0.0002458116],"category_scores_gemma":[0.001144059,0.0002792192,0.0001135314,0.0007443975,0.0001778434,0.00007413819,0.0002591142,0.002198901,0.0002693641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001459835,"about_ca_system_score_gemma":0.001703239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001027045,"about_ca_topic_score_gemma":0.0003895241,"domain_scores_codex":[0.9971847,0.00007862658,0.0004696835,0.0006263393,0.0009720185,0.000668638],"domain_scores_gemma":[0.9981622,0.0003178602,0.0001834741,0.0007721325,0.000235185,0.0003291356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001707084,0.0008822377,0.6801344,0.000267476,0.001003774,0.001785975,0.004527105,0.001875086,0.2670183,0.0005096907,0.009909802,0.03037916],"study_design_scores_gemma":[0.004919206,0.0002814432,0.9712062,0.00006280683,0.0002677564,0.0006537939,0.00002189992,0.008734017,0.007413671,0.0005762335,0.005548438,0.0003144926],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954822,0.0005719597,0.0001365437,0.000325773,0.000871531,0.0005963814,0.00006403482,0.00009301799,0.001858551],"genre_scores_gemma":[0.9900113,0.0005725651,0.007139765,0.0007775844,0.0007449194,0.00003642598,0.00006112959,0.00006346365,0.0005928177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2910719,"threshold_uncertainty_score":0.999966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3063038225","doi":"10.1200/jco.20.00256","title":"Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Randomization; Regimen; Refractory (planetary science); Lymphoblastic Leukemia; Methotrexate; Acute lymphocytic leukemia; Gastroenterology; Clinical trial; Surgery; Leukemia; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.118658632056108,"gpt":0.4594663857692832,"spread":0.3408077537131752,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.02748321,0.0006371228,0.01058477,0.0004937711,0.0001034221,0.00004418324,0.001030955,0.002134092,0.0002970186],"category_scores_gemma":[0.1614222,0.0004645422,0.002532304,0.001061072,0.00159434,0.0003017611,0.000484853,0.005685965,0.0001528334],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003038836,"about_ca_system_score_gemma":0.02821977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001846063,"about_ca_topic_score_gemma":0.00003358585,"domain_scores_codex":[0.9736801,0.007999683,0.01456769,0.001064249,0.001458453,0.001229847],"domain_scores_gemma":[0.8948342,0.09331388,0.007155107,0.0005954647,0.001079831,0.003021565],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8497209,0.009459338,0.005401099,0.00004673789,0.001535355,0.01630354,0.0002351328,0.00009379895,0.0004659149,0.00003563278,0.01054275,0.1061598],"study_design_scores_gemma":[0.8734226,0.09133192,0.003404088,0.0001887425,0.002514324,0.001548429,0.00008505712,0.02076522,0.0000312036,0.0001199606,0.00624303,0.0003454256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9746886,0.000394444,0.003723204,0.01229374,0.003046599,0.003047666,0.00001374034,0.00006933964,0.002722678],"genre_scores_gemma":[0.9538335,0.001542887,0.01698752,0.01406378,0.0132309,0.00008812224,0.00003069969,0.00009908469,0.0001235646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.133939,"threshold_uncertainty_score":0.9997807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109195714","doi":"10.1016/j.bbmt.2013.07.020","title":"Prevalence of Hematopoietic Cell Transplant Survivors in the United States","year":2013,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Health Resources and Services Administration; Therakos; Sigma-Tau Pharmaceuticals; Kiadis Pharma; Genentech; CellGenix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Blue Cross and Blue Shield Association; Swedish Orphan Biovitrum; Emory University; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; Otsuka America; U.S. Navy; Osiris Therapeutics; Celgene; Amgen; Ariad Pharmaceuticals; U.S. Department of Defense; Sanofi; U.S. Department of Health and Human Services; GlaxoSmithKline","keywords":"Medicine; Hematopoietic cell; Specialty; Cohort; Population; Health care; Transplantation; Family medicine; Bone transplantation; Bone marrow transplant; Gerontology; Pediatrics; Internal medicine; Bone marrow transplantation; Stem cell; Haematopoiesis; Surgery; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.01057182767153208,"gpt":0.2460921251503561,"spread":0.235520297478824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002347627,0.00008390196,0.0001796662,0.0001423041,0.00001697394,0.000002326725,0.00008548141,0.00008770666,0.00003649396],"category_scores_gemma":[0.000008413036,0.00005329819,0.00002831291,0.0001598441,0.0002157547,0.00003432068,0.000003368961,0.00009013397,0.00000187572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005023612,"about_ca_system_score_gemma":0.00004933327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001887986,"about_ca_topic_score_gemma":0.00005413662,"domain_scores_codex":[0.9992195,0.0001319959,0.0002598404,0.0001305621,0.0001111069,0.0001469497],"domain_scores_gemma":[0.9993781,0.0003655056,0.00006093891,0.0001033756,0.00005716772,0.0000348567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004413877,0.0003836076,0.3885005,0.006760376,0.00006923427,0.00003343434,0.01147102,0.00001537739,0.591589,0.0003791336,0.00003220605,0.0003247268],"study_design_scores_gemma":[0.01267342,0.002638407,0.4371791,0.0009846154,0.001199731,0.0007272443,0.002280917,0.001533711,0.5390093,0.001421903,0.00004626142,0.0003053457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982585,0.0003970664,0.0003292276,0.0003444722,0.00001589357,0.0003878257,0.0000683722,0.000006784809,0.0001918422],"genre_scores_gemma":[0.9945008,0.004986961,0.0001974325,0.0000779945,0.00000699546,0.00002430701,0.0001721825,0.000005302039,0.00002801606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05257965,"threshold_uncertainty_score":0.2854083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2806544610","doi":"10.1200/jco.2017.76.7228","title":"Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Dasatinib; Imatinib; Cumulative incidence; Internal medicine; Hematopoietic stem cell transplantation; Chemotherapy; Acute lymphocytic leukemia; Philadelphia chromosome; Transplantation; Oncology; Leukemia; Surgery; Lymphoblastic Leukemia; Myeloid leukemia; Chromosomal translocation","retraction":null,"screen_n_in":null,"score":{"opus":0.03012673645879117,"gpt":0.3770404011580003,"spread":0.3469136646992091,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003404539,0.0004819033,0.003618407,0.0005726925,0.00008336984,0.00001747505,0.0005165626,0.0012664,0.00004983515],"category_scores_gemma":[0.006580433,0.00033756,0.0004238955,0.0005719652,0.002507446,0.0002420146,0.0002531933,0.002272555,0.00001391051],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003377578,"about_ca_system_score_gemma":0.01020279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004051775,"about_ca_topic_score_gemma":0.0003267432,"domain_scores_codex":[0.9918674,0.001001367,0.004540141,0.0007701386,0.001048477,0.0007724942],"domain_scores_gemma":[0.9900479,0.00255428,0.003819788,0.0004816466,0.002301405,0.0007949788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8982871,0.003090178,0.06004242,0.00005786063,0.002627683,0.001517797,0.001819467,0.000009386963,0.0004785395,0.00002700921,0.003858636,0.02818396],"study_design_scores_gemma":[0.4191803,0.1158306,0.4535972,0.001227046,0.0007211037,0.007737486,0.0003567925,0.0005382117,0.0003145901,0.00003444529,0.0002093376,0.0002528105],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920275,0.0002013171,0.0002624842,0.004333669,0.0009322471,0.001712934,0.00006960193,0.00001871864,0.0004415211],"genre_scores_gemma":[0.9895511,0.001835488,0.002161526,0.002815405,0.00346393,0.00001790205,0.00004085274,0.00007173832,0.00004209418],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4791068,"threshold_uncertainty_score":0.9999077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016830328","doi":"10.1182/blood-2013-06-509463","title":"Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":247,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Stichting Kinderen Kankervrij; Israel Cancer Association; American Lebanese Syrian Associated Charities; National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Medicine; Cumulative incidence; Internal medicine; Hazard ratio; Gastroenterology; White blood cell; Regimen; Incidence (geometry); Confidence interval; Cohort","retraction":null,"screen_n_in":null,"score":{"opus":0.005616953211833028,"gpt":0.2309892770139484,"spread":0.2253723238021153,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003166788,0.0004232863,0.0009291461,0.0004046508,0.0001633164,0.0001383172,0.0005634244,0.0001551508,0.0004387113],"category_scores_gemma":[0.000196636,0.0002481781,0.0001999573,0.002548011,0.000234762,0.0002298791,0.00027674,0.0005738028,0.0002607103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001898227,"about_ca_system_score_gemma":0.000720036,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02010592,"about_ca_topic_score_gemma":0.001944143,"domain_scores_codex":[0.9964784,0.0002100372,0.0004873079,0.0009089733,0.00117294,0.0007423045],"domain_scores_gemma":[0.9977673,0.0003674309,0.0001563343,0.001232495,0.0001916214,0.0002848452],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002080381,0.001151677,0.9840576,0.000004238586,0.01221903,0.0007109261,0.0008243911,0.00003779895,0.0003972046,0.00001405051,0.0002594624,0.0001155508],"study_design_scores_gemma":[0.01839316,0.001774904,0.9690104,0.00007258842,0.007540546,0.0006012302,0.0006443796,0.001540464,0.00009298034,0.00004499473,0.000003308036,0.0002811142],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962103,0.0001171157,0.0002318568,0.0002264633,0.00002938735,0.002540327,0.0000834363,0.0001048298,0.0004562273],"genre_scores_gemma":[0.9983767,0.00002477293,0.0002711312,0.0002154822,0.000131489,0.00046253,0.0001199268,0.00006674435,0.0003312508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01818512,"threshold_uncertainty_score":0.999997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144921015","doi":"10.1016/s1470-2045(15)00363-0","title":"Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier universitaire de Québec; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"National Cancer Institute; Dana-Farber Cancer Institute; Enzon Pharmaceuticals","keywords":"Medicine; Asparaginase; Internal medicine; Gastroenterology; Pediatrics; Surgery; Leukemia; Lymphoblastic Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.07495321031302048,"gpt":0.3856600473002791,"spread":0.3107068369872586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003619126,0.0007561714,0.00269937,0.0003881197,0.0002432162,0.0001670725,0.001748486,0.0006496086,0.0002334759],"category_scores_gemma":[0.005405413,0.0005585136,0.0001534865,0.001511938,0.0008915167,0.0003188599,0.000801847,0.001699272,0.0003896162],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.005556528,"about_ca_system_score_gemma":0.009747946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001600139,"about_ca_topic_score_gemma":0.000430347,"domain_scores_codex":[0.9928363,0.002071396,0.001176203,0.001085104,0.001011974,0.001819009],"domain_scores_gemma":[0.9931251,0.003453036,0.0005213849,0.00138408,0.0005311613,0.0009852406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9190345,0.01102784,0.00002487761,0.00006567723,0.001742557,0.01461007,0.0049272,0.0002686861,0.001794108,0.0005205336,0.03444077,0.01154321],"study_design_scores_gemma":[0.9497923,0.02157588,0.0002322552,0.0001365389,0.001031292,0.0006629527,0.0006938564,0.01155774,0.0006454264,0.0004442022,0.01263896,0.000588647],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760786,0.0005388503,0.0004444482,0.006615662,0.001721826,0.008254257,0.0001094784,0.0002038323,0.006033089],"genre_scores_gemma":[0.9892966,0.0004554458,0.001854471,0.00330694,0.001940688,0.002089414,0.0003982778,0.0001581172,0.0005000377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03075779,"threshold_uncertainty_score":0.9996867,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2292251821","doi":"10.3324/haematol.2015.137380","title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Asparaginase; Medicine; Lymphoblastic Leukemia; Antibody; Immunology; Intensive care medicine; Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.05685968397073798,"gpt":0.3407853727054265,"spread":0.2839256887346885,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000207453,0.00007253928,0.0001856751,0.00006733814,0.00006027752,0.000006681715,0.00002259472,0.00005109194,0.00001245826],"category_scores_gemma":[0.0001783821,0.00004671151,0.00002069236,0.00006276596,0.0001578543,0.00003855362,0.00004570267,0.00002529958,0.000003602154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008899382,"about_ca_system_score_gemma":0.00002614253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001387952,"about_ca_topic_score_gemma":0.000001398625,"domain_scores_codex":[0.9993334,0.00004124749,0.0001897881,0.0002087975,0.0001076905,0.0001191086],"domain_scores_gemma":[0.9991821,0.0003946762,0.00008907915,0.0001576964,0.0001161047,0.00006032192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003259319,0.0009644303,0.006102022,0.002420024,0.0006404647,0.0003247274,0.001260483,5.879379e-7,0.3976807,0.08202347,0.03530323,0.4700206],"study_design_scores_gemma":[0.02907164,0.002144471,0.3027786,0.003155122,0.0006521264,0.003885255,0.008033942,0.004839957,0.6003988,0.009773438,0.03434733,0.0009192191],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633777,0.0001163872,0.01258022,0.02242102,0.00004164731,0.0008456714,0.0000246448,0.00003181131,0.0005609713],"genre_scores_gemma":[0.9917821,0.000557951,0.007170573,0.0001016752,0.00001011465,0.0001029336,0.00001269735,0.000006440794,0.0002555112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4691013,"threshold_uncertainty_score":0.190484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990147363","doi":"10.1111/bjh.12882","title":"Outcome for children and young people with <scp>E</scp>arly <scp>T</scp>‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, <scp>UKALL</scp> 2003","year":2014,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Medical Research Council; Hospital for Sick Children; Leukaemia and Lymphoma Research","keywords":"Medicine; Pediatrics; Acute lymphocytic leukemia; Internal medicine; Lymphoblastic Leukemia; Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.01256972215183671,"gpt":0.2699212764645583,"spread":0.2573515543127216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001358835,0.0008918206,0.002953335,0.0007735917,0.0003917396,0.0003146096,0.0007859416,0.000801657,0.00001484539],"category_scores_gemma":[0.009461771,0.0007871399,0.0003996778,0.0008451119,0.0006619713,0.0005515182,0.0002159821,0.001275022,0.0000756813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006300061,"about_ca_system_score_gemma":0.00234757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003277447,"about_ca_topic_score_gemma":0.0001880719,"domain_scores_codex":[0.9932532,0.0005903161,0.002066091,0.001072894,0.001314416,0.001703082],"domain_scores_gemma":[0.9905415,0.004263489,0.001622338,0.0006565255,0.001675246,0.001240961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"case_report","study_design_scores_codex":[0.001484829,0.00261648,0.3589117,0.002439456,0.003454841,0.02655636,0.002083004,0.0000512318,0.001811396,0.000437357,0.5985688,0.001584586],"study_design_scores_gemma":[0.09192026,0.02078236,0.1760377,0.003863497,0.002108042,0.6694129,0.001286347,0.002191958,0.009078632,0.0003685459,0.02258272,0.0003670614],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9629835,0.0007190824,0.003522823,0.0001850528,0.0003066232,0.02684259,0.0002401815,0.0001456841,0.005054415],"genre_scores_gemma":[0.9724774,0.0002173316,0.004926782,0.001041742,0.0007404687,0.009412399,0.0002001763,0.0004468189,0.01053691],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6428565,"threshold_uncertainty_score":0.999458,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105983753","doi":"10.1359/jbmr.090202","title":"Advanced Vertebral Fracture Among Newly Diagnosed Children With Acute Lymphoblastic Leukemia: Results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Research Program","year":2009,"lang":"en","type":"article","venue":"Journal of Bone and Mineral Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Manitoba; University of Toronto; Western University; Brock University; McMaster University; University of Calgary; University of Ottawa; McGill University; University of British Columbia; University of Alberta; Université de Montréal; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Lymphoblastic Leukemia; Osteoporosis; Pediatrics; Internal medicine; Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.01873535632661442,"gpt":0.3214774374143973,"spread":0.3027420810877828,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005574549,0.0002291092,0.0005961722,0.001378879,0.0004609318,0.0001523207,0.0004868302,0.0003174389,0.000008214997],"category_scores_gemma":[0.003425419,0.0001195801,0.0001405619,0.002871682,0.0004189187,0.0003264542,0.00009461979,0.0024762,0.000001784245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002587023,"about_ca_system_score_gemma":0.004751661,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06817465,"about_ca_topic_score_gemma":0.08193652,"domain_scores_codex":[0.9931985,0.001012216,0.0008968018,0.0003428888,0.003435754,0.001113914],"domain_scores_gemma":[0.9960689,0.0009913807,0.0003660155,0.000483048,0.001579814,0.0005108269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007087709,0.001083749,0.9385396,0.0000920619,0.0003168324,0.002485034,0.00460188,0.0005571967,0.002020461,0.00002732813,0.02231624,0.02087195],"study_design_scores_gemma":[0.01236191,0.004988746,0.9800855,0.0003350806,0.0001166976,0.0005830348,0.0005691456,0.0005378683,0.0001192057,0.0001023012,0.00008238792,0.0001181288],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920604,0.0003930755,0.000001345257,0.005608748,0.00003623352,0.001567964,0.00002720051,0.00000733105,0.000297692],"genre_scores_gemma":[0.9984756,0.0003384468,0.0002199476,0.0001914675,0.0002658482,0.00002844534,0.00003613715,0.00002752039,0.0004166197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04154593,"threshold_uncertainty_score":0.9998251,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092134373","doi":"10.1002/tera.10043","title":"Teratogen update: Azathioprine and 6‐mercaptopurine","year":2002,"lang":"en","type":"article","venue":"Teratology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Library science; Medicine; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.01852185953585475,"gpt":0.2653986013195777,"spread":0.2468767417837229,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008190478,0.0001437995,0.0003148499,0.0001347915,0.00006013686,0.00001899715,0.00008605903,0.0001260936,0.002853286],"category_scores_gemma":[0.00009323053,0.0001169112,0.00003324475,0.0001548463,0.0001849233,0.0000537406,0.0001207948,0.0002123777,0.0008239025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007636629,"about_ca_system_score_gemma":0.00003996491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001631188,"about_ca_topic_score_gemma":0.000003751936,"domain_scores_codex":[0.9989237,0.00004185583,0.0002081447,0.0003059404,0.0001594462,0.0003608689],"domain_scores_gemma":[0.9993206,0.00006219674,0.00002942514,0.0003175833,0.00006530106,0.000204845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001233159,0.001641839,0.2947787,0.0008992158,0.001004231,0.01484712,0.002614969,0.000003444115,0.103124,0.0409699,0.3435534,0.1953301],"study_design_scores_gemma":[0.02536124,0.002281448,0.04106792,0.000174555,0.000362923,0.04749756,0.000137501,0.02442376,0.04320716,0.001428772,0.8129176,0.001139518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782587,0.001073949,0.0001639714,0.008845569,0.00009365767,0.000232494,0.000005721075,0.0001175652,0.01120833],"genre_scores_gemma":[0.9918675,0.0002610211,0.001586436,0.002690186,0.0001407217,0.00002015923,0.00001552721,0.0000245695,0.003393835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4693643,"threshold_uncertainty_score":0.999954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071035298","doi":"10.1182/blood.v100.10.3832","title":"Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":216,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Methotrexate; Genotype; Pharmacogenetics; Lymphoblastic Leukemia; Oncology; Internal medicine; Drug resistance; Leukemia; Childhood leukemia; Acute lymphocytic leukemia; Medicine; Immunology; Biology; Pharmacology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.04436777445642769,"gpt":0.2947404738922528,"spread":0.2503726994358251,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005991458,0.0002752427,0.0005429571,0.0003656052,0.0001187563,0.0000327155,0.000221113,0.0001952717,0.00006129958],"category_scores_gemma":[0.00118774,0.0002011885,0.00007121477,0.0006541599,0.0001068388,0.00011579,0.0001580339,0.0003422263,0.00003154453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002196149,"about_ca_system_score_gemma":0.0002136672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007915095,"about_ca_topic_score_gemma":0.00001298644,"domain_scores_codex":[0.9977081,0.0002052384,0.000575912,0.0004719516,0.0005457331,0.0004930429],"domain_scores_gemma":[0.9981921,0.0008286044,0.0001228457,0.0004634289,0.00008990279,0.0003031307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001150565,0.002129376,0.4177686,0.0007782185,0.002726088,0.003113861,0.04407078,0.0001178918,0.5159531,0.003163341,0.001396263,0.00763193],"study_design_scores_gemma":[0.0194505,0.0009057627,0.9197072,0.00023777,0.001171127,0.003163591,0.0002428948,0.003612413,0.05075177,0.0002356055,0.00009399202,0.0004273895],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960442,0.0008398428,0.000048348,0.001310838,0.00005120812,0.000824904,0.00009336051,0.00003131459,0.0007560003],"genre_scores_gemma":[0.9970986,0.00007373151,0.001359049,0.0004052095,0.00007846409,0.00005575339,0.000007300539,0.00004661009,0.0008753213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5019386,"threshold_uncertainty_score":0.8204229,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1901988103","doi":"10.1016/j.ccell.2015.07.016","title":"Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia","year":2015,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Cancer research; Dasatinib; Leukemia; Lymphoid leukemia; Biology; Immunology; Stromal cell; Bone marrow; Imatinib; Myeloid leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.02531810677530771,"gpt":0.3107995972889939,"spread":0.2854814905136862,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003558994,0.0002746249,0.000618999,0.000203041,0.00002639775,0.00001453876,0.0003048094,0.000233852,0.0004347139],"category_scores_gemma":[0.0003100869,0.0002412774,0.0001111122,0.0007513285,0.0002458269,0.0001131848,0.0001571273,0.0003113613,0.000185447],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006793341,"about_ca_system_score_gemma":0.005939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00240655,"about_ca_topic_score_gemma":0.00009466898,"domain_scores_codex":[0.9974585,0.0000888405,0.0005701054,0.0004811679,0.0007416276,0.0006597841],"domain_scores_gemma":[0.9981445,0.0002434763,0.0001600718,0.0005753781,0.0003562051,0.0005203605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03275752,0.002751906,0.08482717,0.003101666,0.001383714,0.006008436,0.01564488,0.01004384,0.5149559,0.0003497867,0.3047997,0.02337549],"study_design_scores_gemma":[0.1496141,0.004189141,0.06037811,0.002457096,0.00147867,0.000479301,0.002257631,0.06563827,0.6782728,0.0003088462,0.03305651,0.001869465],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9761428,0.001499823,0.0001662485,0.0003089497,0.0003408354,0.0006108509,0.00003559755,0.00007760429,0.0208173],"genre_scores_gemma":[0.992781,0.0003891036,0.0005294688,0.0002958771,0.0002238482,0.000068597,0.00004680088,0.00007099951,0.005594282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2717432,"threshold_uncertainty_score":0.9996964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606110123","doi":"10.1016/s2352-3026(17)30052-2","title":"Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries","year":2017,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Centers for Disease Control and Prevention; Partenariat Canadien Contre Le Cancer; Swiss Re; World Health Organization; Swiss Cancer Research Foundation; Cancer Institute NSW; Cancer Research UK","keywords":"Medicine; Pediatrics; Demography; Childhood leukaemia; Population; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.0781453487170645,"gpt":0.3765434257869886,"spread":0.2983980770699241,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007426172,0.0002307653,0.001923425,0.0000994551,0.0002080083,0.00005033339,0.001245547,0.0001766195,0.00001565022],"category_scores_gemma":[0.00162465,0.0001738752,0.00004506009,0.00008594363,0.0004613831,0.0001055536,0.0004155436,0.0002568055,9.74797e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006904175,"about_ca_system_score_gemma":0.0003432231,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02086553,"about_ca_topic_score_gemma":0.01511522,"domain_scores_codex":[0.9977987,0.0001886569,0.0007007034,0.0005088753,0.000403233,0.0003998773],"domain_scores_gemma":[0.9943679,0.002897717,0.0007037685,0.001868472,0.00009235287,0.00006980721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001821263,0.0003827199,0.983286,0.0001162438,0.0003717563,0.00001448165,0.001301453,0.000009649812,0.0000356281,0.0001536136,0.01210169,0.0004055619],"study_design_scores_gemma":[0.01914946,0.0005012041,0.9756145,0.0001576055,0.0004255656,0.000009137763,0.0008257395,0.001166521,0.000613099,0.0009339484,0.0004360971,0.000167119],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847814,0.0006571324,0.0003106556,0.001927036,0.0001126042,0.002008706,0.0101475,0.00002335044,0.00003163859],"genre_scores_gemma":[0.992602,0.00002344451,0.001040998,0.0001376474,0.0001905178,0.00008861966,0.005845897,0.0000335954,0.00003727405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0173282,"threshold_uncertainty_score":0.9856546,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2893765519","doi":"10.1038/s41375-018-0265-z","title":"Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Vanderbilt University; York University; Eberhard Karls Universität Tübingen; McMaster University; NYU Langone Medical Center; Kaiser Permanente","keywords":"Medicine; Refractory (planetary science); Minimal residual disease; Salvage therapy; Hematopoietic stem cell transplantation; Internal medicine; Transplantation; Lymphoblastic Leukemia; Leukemia; Chemotherapy; Pediatrics; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.008638915841045569,"gpt":0.2502595223216064,"spread":0.2416206064805608,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003354779,0.0006247949,0.0008315042,0.0009417157,0.0001866393,0.00006160654,0.0005334077,0.0005109253,0.0004101118],"category_scores_gemma":[0.0004439472,0.0004991594,0.0001371805,0.001793058,0.0005100268,0.000400026,0.0002928819,0.0009351447,0.001590535],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01866002,"about_ca_system_score_gemma":0.00747789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004241764,"about_ca_topic_score_gemma":0.0001694352,"domain_scores_codex":[0.9951159,0.0001323348,0.0008123514,0.001078398,0.001470884,0.001390168],"domain_scores_gemma":[0.9970337,0.0003903526,0.0002673417,0.00114523,0.00057083,0.0005925641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01144023,0.0009078811,0.9405174,0.0005372877,0.0004748441,0.001917524,0.001800312,0.000147459,0.001891224,0.0003166382,0.03093801,0.009111197],"study_design_scores_gemma":[0.04077924,0.005008291,0.9426511,0.0003794248,0.0005885451,0.0001715952,0.00009621889,0.004569176,0.00102689,0.0001405993,0.003631235,0.0009577061],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854369,0.00008454445,0.0004056576,0.0001102078,0.0003986958,0.001005581,0.0000339324,0.0002292819,0.01229526],"genre_scores_gemma":[0.993571,0.00009825661,0.001385215,0.0009124881,0.001019104,0.00007631377,0.0001434734,0.0001747525,0.002619406],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02933901,"threshold_uncertainty_score":0.999746,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075626785","doi":"10.1046/j.1365-2141.2003.04229.x","title":"Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21","year":2003,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Disease; Trisomy; Down syndrome; Rash; Hematology; Preleukemia; Leukemia; Pathology; Pediatrics; Immunology; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.02774968511796044,"gpt":0.3250905824510643,"spread":0.2973408973331039,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001218337,0.0005884363,0.007222532,0.001249674,0.00005317689,0.00003090401,0.0006232685,0.0009984946,0.0002051106],"category_scores_gemma":[0.0006414796,0.0004966402,0.0008956646,0.001086366,0.0004821102,0.0001920347,0.00007341462,0.002336126,0.00001592424],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001309315,"about_ca_system_score_gemma":0.01023248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001910734,"about_ca_topic_score_gemma":0.0002532623,"domain_scores_codex":[0.9936903,0.0005511141,0.003227076,0.0005033857,0.001101594,0.0009265127],"domain_scores_gemma":[0.9957763,0.0006831653,0.001917277,0.0004729365,0.0006644094,0.0004859282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.0006689622,0.000463622,0.0001443515,0.02279688,0.0009952799,0.1843021,0.0001895817,0.000003122689,0.000002516903,0.00009078255,0.006259105,0.7840837],"study_design_scores_gemma":[0.006691525,0.0009040277,0.00005278411,0.05098025,0.00120466,0.5669172,0.00007400846,0.000005652566,0.00001245886,0.00005538239,0.3728272,0.0002749232],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01218782,0.9837465,0.0005714238,0.00007391121,0.0002197935,0.001306236,0.00005307296,0.00001218327,0.001829024],"genre_scores_gemma":[0.001235744,0.9943379,0.003773677,0.00009051685,0.0001155822,0.00004590862,0.00003457781,0.0001350539,0.000231108],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7838088,"threshold_uncertainty_score":0.9999655,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974895424","doi":"10.1200/jco.2003.07.056","title":"Homocysteine, Pharmacogenetics, and Neurotoxicity in Children With Leukemia","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; National Institute of General Medical Sciences; McGill University","keywords":"Medicine; Methylenetetrahydrofolate reductase; Methotrexate; Homocysteine; Hyperhomocysteinemia; Gastroenterology; Internal medicine; Toxicity; Neurotoxicity; Pharmacology; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.06536491631372009,"gpt":0.4358240741328692,"spread":0.3704591578191491,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002598374,0.0001280703,0.001044714,0.0001681303,0.00002203346,0.000007676411,0.0001241979,0.0002568696,0.00007171433],"category_scores_gemma":[0.003645338,0.0000829073,0.0001215175,0.0002024847,0.0003468147,0.00006748123,0.00004084568,0.001235652,0.000007772683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004266038,"about_ca_system_score_gemma":0.005161442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002242294,"about_ca_topic_score_gemma":0.00001740182,"domain_scores_codex":[0.9971389,0.0005671098,0.001406917,0.00019814,0.000407118,0.0002818143],"domain_scores_gemma":[0.9973002,0.001175572,0.0006096807,0.0001493051,0.0002599604,0.0005052682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002854083,0.0006702477,0.9665485,0.00001842461,0.0002807781,0.00154944,0.00002869052,0.00004828728,0.0005286883,0.0000832883,0.001406083,0.0259835],"study_design_scores_gemma":[0.03252347,0.01293525,0.9311302,0.0000695826,0.0002334444,0.0106305,0.00002852461,0.0003063817,0.0009008715,0.0001008295,0.01103148,0.0001094292],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995337,0.0003453716,0.0001868843,0.001031368,0.0001642882,0.0003051543,0.000001277868,0.000004843523,0.002623817],"genre_scores_gemma":[0.9916949,0.0007710345,0.005260967,0.001717693,0.0003784071,0.000003025281,5.189216e-7,0.00001889918,0.0001545894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03541825,"threshold_uncertainty_score":0.9156176,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155568574","doi":"10.1200/jco.2006.05.9055","title":"Comparison of Long-Term Neurocognitive Outcomes in Young Children With Acute Lymphoblastic Leukemia Treated With Cranial Radiation or High-Dose or Very High-Dose Intravenous Methotrexate","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Hospital for Sick Children; University of Toronto; Pediatric Oncology Group of Ontario; American Society of Clinical Oncology","keywords":"Medicine; Neurocognitive; Methotrexate; Cohort; Pediatrics; Chemotherapy; Retrospective cohort study; Population; Acute lymphocytic leukemia; Internal medicine; Leukemia; Lymphoblastic Leukemia; Cognition","retraction":null,"screen_n_in":null,"score":{"opus":0.04696036296061799,"gpt":0.4126862246074022,"spread":0.3657258616467842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001592435,0.0004794913,0.003929016,0.0006907535,0.0000716498,0.00002945566,0.0003828704,0.0006332258,0.0001415712],"category_scores_gemma":[0.002454085,0.0002590643,0.0002974184,0.0008293667,0.0007116027,0.0002882479,0.00009391981,0.001496403,0.00001549405],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002083852,"about_ca_system_score_gemma":0.01019094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001779582,"about_ca_topic_score_gemma":0.002640629,"domain_scores_codex":[0.9928871,0.001108857,0.003667058,0.0005199442,0.001139962,0.0006770764],"domain_scores_gemma":[0.9888808,0.006351205,0.003074464,0.0003465459,0.0008694921,0.0004775427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1433231,0.004205093,0.8072281,0.00005636414,0.002033409,0.01184037,0.0001401401,0.0005684822,0.000355216,0.00001158278,0.0001961125,0.03004208],"study_design_scores_gemma":[0.07382645,0.04731909,0.8694404,0.0003192276,0.002289858,0.004928017,0.00005018101,0.0006721063,0.0008791011,0.00001726918,0.00001107253,0.0002472092],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963931,0.00004124065,0.001399731,0.0005708869,0.0003548349,0.0009974858,0.00003991025,0.00002806991,0.0001747013],"genre_scores_gemma":[0.993959,0.0002635809,0.004185046,0.0002976144,0.0007906788,0.00002009063,0.00006108818,0.00008183875,0.0003410458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06949664,"threshold_uncertainty_score":0.9999862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015698333","doi":"10.1200/jco.19.03024","title":"Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Discontinuation; Asparaginase; Internal medicine; Hazard ratio; Acute lymphocytic leukemia; Lymphoblastic Leukemia; Chemotherapy; Leukemia; Surgery; Pediatrics; Oncology; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.08360919335721549,"gpt":0.4559111065686997,"spread":0.3723019132114842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003910013,0.0002947643,0.002803006,0.0001864379,0.0000420373,0.0000142106,0.0005821779,0.0007168851,0.0001831742],"category_scores_gemma":[0.02650578,0.0001645262,0.001115307,0.0004494335,0.0004598621,0.0001596604,0.0001957768,0.002459797,0.0000463411],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003270227,"about_ca_system_score_gemma":0.01144558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005331789,"about_ca_topic_score_gemma":0.00008553405,"domain_scores_codex":[0.9921239,0.001145413,0.004882282,0.0004485075,0.0009379163,0.0004620082],"domain_scores_gemma":[0.9847177,0.009988556,0.003689668,0.000497994,0.0004006353,0.0007054303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01744814,0.004019729,0.9036388,0.00001020368,0.002168897,0.01120827,0.0006873524,0.0003717032,0.0003983077,0.00005678204,0.009832243,0.05015951],"study_design_scores_gemma":[0.02383403,0.03535186,0.935304,0.0001110662,0.0007445494,0.002420575,0.00008911583,0.0009673308,0.0000336993,0.0001649599,0.0008517687,0.0001270192],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9778377,0.0001277041,0.0006391623,0.01938331,0.0005351166,0.0005667864,0.00003495572,0.00001304672,0.000862257],"genre_scores_gemma":[0.9923536,0.0002223267,0.001157128,0.004135996,0.002015242,0.000009959409,0.00003763867,0.00003720769,0.00003094535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0500325,"threshold_uncertainty_score":0.9998416,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405130232","doi":"10.1056/nejmoa2411680","title":"Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children","year":2024,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; BC Children's Hospital; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; St. Baldrick's Foundation","keywords":"Blinatumomab; Lymphoblastic Leukemia; Medicine; Leukemia; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.007777328390129835,"gpt":0.2773377539845645,"spread":0.2695604255944346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002289116,0.0003010808,0.0009623395,0.001594522,0.0000308089,0.00003124941,0.0002886028,0.0001861799,0.000347066],"category_scores_gemma":[0.001080544,0.0001968716,0.0001295595,0.001193776,0.0001829814,0.0001911942,0.00006780667,0.001577664,0.00003572708],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003438745,"about_ca_system_score_gemma":0.005428166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007996628,"about_ca_topic_score_gemma":0.0001030139,"domain_scores_codex":[0.9964476,0.000193805,0.001127332,0.0003288944,0.001344107,0.0005582641],"domain_scores_gemma":[0.9979629,0.0007956442,0.0002176263,0.0002767199,0.0001834182,0.0005636976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02125985,0.0004590568,0.3121553,0.000833065,0.001551284,0.06116945,0.007796947,0.001775651,0.01292145,0.0004087881,0.1259114,0.4537578],"study_design_scores_gemma":[0.6518475,0.01687362,0.1913557,0.01358888,0.002330034,0.05997994,0.000693178,0.01852966,0.004385131,0.003864073,0.03567414,0.0008780816],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839804,0.008242935,0.001497061,0.003323254,0.0006715357,0.0003381998,0.00001885997,0.00003285179,0.001894967],"genre_scores_gemma":[0.9916427,0.003150816,0.0006696499,0.0002545711,0.003188072,0.000002864364,0.00001530819,0.000058046,0.001017938],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6305876,"threshold_uncertainty_score":0.9629334,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128800587","doi":"10.1016/s0140-6736(02)08065-0","title":"Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia","year":2002,"lang":"en","type":"article","venue":"The Lancet","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Dana-Farber Cancer Institute","keywords":"Thymidylate synthase; Methotrexate; Genotyping; Biology; Genotype; Internal medicine; Molecular biology; Cancer research; Medicine; Immunology; Gene; Genetics; Chemotherapy; Fluorouracil","retraction":null,"screen_n_in":null,"score":{"opus":0.03945044235028597,"gpt":0.2894032904404977,"spread":0.2499528480902117,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003122313,0.0001545385,0.0005925367,0.00005703097,0.00007486178,0.000009137168,0.000439848,0.00008348568,0.0002147447],"category_scores_gemma":[0.0002610959,0.0000765447,0.0001076625,0.0002702085,0.0005488134,0.00003859644,0.0002478449,0.0002086712,0.00003348353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001348271,"about_ca_system_score_gemma":0.00008451745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001166936,"about_ca_topic_score_gemma":0.000003626636,"domain_scores_codex":[0.9985431,0.00008520226,0.0003624386,0.0001877815,0.0004735609,0.0003479437],"domain_scores_gemma":[0.9983596,0.0003292784,0.0001693243,0.0009777988,0.00007322989,0.00009072918],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003516177,0.0007214726,0.37306,0.00163297,0.003094516,0.0004328366,0.004848886,0.0001329555,0.5293135,0.004302179,0.06627237,0.01267209],"study_design_scores_gemma":[0.03850367,0.001300715,0.6393042,0.001189617,0.0033141,0.003495635,0.0002913055,0.0449034,0.2595979,0.001631982,0.005640569,0.0008269452],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899914,0.0007565907,0.00007846482,0.005834385,0.0001137505,0.0003245165,0.0001017193,0.00002619534,0.00277297],"genre_scores_gemma":[0.9963351,0.00032372,0.0002798268,0.0007341214,0.0002445435,0.000009783785,0.00000238628,0.00002463751,0.002045874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2697156,"threshold_uncertainty_score":0.3121402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060193341","doi":"10.1038/sj.leu.2403673","title":"High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative","year":2005,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Trisomy; Concordance; Context (archaeology); Internal medicine; Oncology; Lymphoblastic Leukemia; Medicine; Chromosome; Cancer; Leukemia; Biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01084619977607484,"gpt":0.274874083981728,"spread":0.2640278842056532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001272278,0.001209308,0.002556153,0.000462689,0.0008270158,0.0001869901,0.0006275857,0.000825043,0.0001085355],"category_scores_gemma":[0.0006756648,0.0008178379,0.0001419937,0.001255672,0.001491199,0.0006599043,0.0006959186,0.002261658,0.00001373771],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01830267,"about_ca_system_score_gemma":0.004105499,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0113329,"about_ca_topic_score_gemma":0.01080185,"domain_scores_codex":[0.9925715,0.001004761,0.001290285,0.001895924,0.001516204,0.00172137],"domain_scores_gemma":[0.9938946,0.002989607,0.001431565,0.0006704807,0.0004598705,0.0005538259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009422596,0.0005550795,0.9477859,0.00007388105,0.006197052,0.0001454073,0.003463048,0.000271558,0.000104227,0.0000698664,0.009586681,0.02232473],"study_design_scores_gemma":[0.0656907,0.01291916,0.9115585,0.0003581293,0.004489681,0.0005840035,0.001530567,0.001015207,0.0002555334,0.0001907079,0.000269516,0.001138281],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831786,0.008227015,0.0003293205,0.001230535,0.0001115031,0.004878652,0.001600053,0.0002067937,0.0002375443],"genre_scores_gemma":[0.981158,0.010215,0.003611891,0.001174664,0.0008552209,0.001961123,0.000580695,0.0002030784,0.0002403032],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0562681,"threshold_uncertainty_score":0.9994273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2037066552","doi":"10.7326/0003-4819-156-11-201206050-00002","title":"Secondary Gastrointestinal Cancer in Childhood Cancer Survivors","year":2012,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Gastrointestinal cancer; Cancer; Population; Internal medicine; Proportional hazards model; Relative risk; Cohort study; Colorectal cancer; Oncology; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.03920970467366092,"gpt":0.3707140192854208,"spread":0.3315043146117599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007467615,0.0002302104,0.0006185555,0.0003919676,0.00002091448,0.000003385241,0.0002346133,0.00006826145,0.005187492],"category_scores_gemma":[0.0007773988,0.0001661093,0.00009709863,0.0003701464,0.0003211836,0.0001607399,0.0001060563,0.0005854489,0.00002934113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002016744,"about_ca_system_score_gemma":0.0005205958,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02512666,"about_ca_topic_score_gemma":0.001197155,"domain_scores_codex":[0.9976313,0.0000701442,0.0006267726,0.0002430186,0.0006997513,0.0007290801],"domain_scores_gemma":[0.9984596,0.0002640016,0.0001925,0.0002729842,0.0003389653,0.0004719483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001044696,0.0004872005,0.9243745,0.0003352011,0.0001921158,0.0001900122,0.002513421,0.0000108922,0.0103336,0.00011062,0.02291917,0.03748855],"study_design_scores_gemma":[0.003961764,0.001027011,0.9709381,0.006011715,0.00005716625,0.0007431695,0.0005132911,0.0002285778,0.01275058,0.0000588645,0.003541476,0.0001682472],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9717657,0.006580608,0.0001436996,0.01093503,0.0004911576,0.000284553,0.00004158999,0.000027123,0.009730531],"genre_scores_gemma":[0.9926405,0.0008986134,0.0001704674,0.003592888,0.001413099,0.00004610846,0.000008091429,0.0000374216,0.001192843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04656362,"threshold_uncertainty_score":0.9957219,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2087111337","doi":"10.1038/sj.leu.2401980","title":"Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)","year":2000,"lang":"en","type":"review","venue":"Leukemia","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Medical Center, University of Rochester; National Institutes of Health; McMaster University; National Cancer Institute; Dana-Farber Cancer Institute","keywords":"Medicine; Vincristine; Internal medicine; Asparaginase; Acute lymphocytic leukemia; Methotrexate; Cancer; Chemotherapy; Clinical trial; Pediatrics; Oncology; Leukemia; Surgery; Cyclophosphamide; Lymphoblastic Leukemia","retraction":null,"screen_n_in":null,"score":{"opus":0.03803873145194273,"gpt":0.3568628924867702,"spread":0.3188241610348275,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006516253,0.001943682,0.006244837,0.0009370314,0.0002684168,0.0001270153,0.001481456,0.001635644,0.0002318913],"category_scores_gemma":[0.0007541648,0.001398127,0.001309715,0.001776591,0.001256967,0.0003647073,0.0003239925,0.001475425,0.0001907348],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01690611,"about_ca_system_score_gemma":0.05467226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002576309,"about_ca_topic_score_gemma":0.0004088359,"domain_scores_codex":[0.9905188,0.0002595913,0.003064821,0.002320394,0.001847885,0.001988491],"domain_scores_gemma":[0.9925804,0.001240352,0.001844226,0.002665155,0.0006839262,0.0009860044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.009871399,0.0004080865,0.0001457049,0.03755565,0.009045722,0.00107831,0.0002272236,0.0004673264,0.00001949132,0.0001861134,0.0749902,0.8660048],"study_design_scores_gemma":[0.03242785,0.002084082,0.000221389,0.05005363,0.009194632,0.001293793,0.000009503324,0.0003154017,0.000087131,0.00002195467,0.9028364,0.001454197],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001234017,0.8135005,0.000920351,0.000196165,0.0006816383,0.1658188,0.01007773,0.0006669546,0.006903869],"genre_scores_gemma":[0.00009546552,0.9037201,0.003523831,0.0003719035,0.00161196,0.07691276,0.003687029,0.0006373845,0.009439567],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8645506,"threshold_uncertainty_score":0.9996604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}